SLC22A3 and colorectal cancer: In summary, this thorough evaluation of SLC22A3 as a prognostic biomarker in colorectal cancer, integrating risk factor analysis, ROC curves, and DCA, establishes a robust framework for assessing the predictive accuracy and clinical relevance of the nomogram.